VACCINE RESEARCH

SERVICES 

READ OUR STORY

Etna Biotech, a Zydus Vaccine research centre in Catania

​

Etna Biotech is a vaccine research center headquartered in Catania. Start up of the former Swiss Serum and Vaccine Institute, later Berna Biotech, Etna Biotech is a company whose key competencies lie in researching and developing vaccines and immunotherapeutics for infectious diseases and other chronic illnesses.

 

Etna Biotech was funded in 2001 and has been acquired in 2008 by the Zydus and is one of the two state-of-the-art R&D centers of the Vaccine Technology ​Centre (VTC) in India, the vaccine division of Zydus Group. 

​

Zydus Cadila, a leading Indian Pharmaceutical company is a fully integrated, global healthcare provider. With in-depth domain expertise in the field of healthcare, it has strong capabilities across the spectrum of the pharmaceutical value chain. From formulations to active pharmaceutical ingredients and animal healthcare products to wellness products, Zydus has earned a reputation amongst Indian pharmaceutical companies for providing comprehensive and complete healthcare solutions.

​

One of the salient features of Zydus is its rich history and lineage. The origin of the company dates all the way back to the 1950s. The company was founded in the year 1952 by Mr. Ramanbhai B. Patel (late), a first-generation entrepreneur and a doyen in the field of Indian Pharmaceuticals.

​

In 1995, the group was restructured and thus was formed Cadila Healthcare under the aegis of the Zydus group. From a humble turnover Rs. 250 crores in 1995 the group witnessed a significant financial growth and registered a turnover of over Rs. 11600 crores in FY18.

​

Adhering to its brand promise of being dedicated to life in all its dimensions, Zydus continues to innovate with an unswerving focus to address the unmet healthcare needs. Simultaneously it rededicates itself to its mission of creating healthier, happier communities across the globe.

 

Etna Biotech is fully integrated in the Zydus Cadila Group and operates in tight collaboration with the Vaccine Technology Center, applying cutting edge technologies for the early stage vaccine research.

 

Etna Biotech has participated in previuos FP programmes and currently is involved in FP7 and H2020 programme of the EU, as well as in national grant programmes funded by EU.